ABSTRACT Background and Aims: Familial hypercholesterolemia (FH) is a common genetic disorder. The prevalence of FH in premature coronary artery disease (CAD) in Sri Lanka was unknown before this study. Materials and Methods: A cross-sectional study was conducted in 602 individuals aged 18–60 years with CAD. FH was diagnosed using the Dutch Lipid Clinic Network (DLCN) score. Results: The prevalence of definite FH was 0.67% (95% confidence interval CI: 0.18–1.7), with probable FH of 4.1% (95% CI: 2.7–6.1) and possible FH of 18.4% (95% CI: 15.4–21.7). The mean age at onset of early-onset CAD was 48.3 years (standard deviation SD = 6.9). The mean low-density lipoprotein cholesterol (LDL-C) levels were highest in the probable and definite FH groups: 260.5 mg/dL (SD = 39.2) and 420.7 mg/dL (SD = 129.3), respectively. The prevalence of diabetes and obesity was similar in patients with and without FH. Among those not on statins ( n = 352), the mean LDL-C was 118.6 mg/dL (SD = 23.9 mg/dL). Among the 250 patients on statins, the target LDL-C level of <55 mg/dL was achieved by 34 (13.6%), whereas among the total population, it was 5.6%. The mean LDL-C level of patients receiving statins was 76.7 mg/dL. Among the correlations for the probability of having FH, a first-degree relative with premature coronary and vascular diseases had a strong correlation (Cramér’s V = 0.7). In the multivariate logistic regression analysis, higher LDL-C levels were significantly associated with probable/definite FH, with each 1 mg/dL increase in LDL-C corresponding to 8% higher odds of FH (odds ratio = 1.08 95% CI: 1.05–1.11; P = 0.001). Conclusions: FH is relatively common in patients with premature CAD. These results highlight the need to promote FH identification in patients with premature CAD.
Matthias et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: